PT2686011T - Vacina contra npi - Google Patents

Vacina contra npi

Info

Publication number
PT2686011T
PT2686011T PT127252872T PT12725287T PT2686011T PT 2686011 T PT2686011 T PT 2686011T PT 127252872 T PT127252872 T PT 127252872T PT 12725287 T PT12725287 T PT 12725287T PT 2686011 T PT2686011 T PT 2686011T
Authority
PT
Portugal
Prior art keywords
ipn vaccine
ipn
vaccine
Prior art date
Application number
PT127252872T
Other languages
English (en)
Inventor
Evensen ØYSTEIN
Ritchie Gordon
Bakke Jøssund Trude
Mutoloki Stephen
Original Assignee
Benchmark Animal Health Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Benchmark Animal Health Ltd filed Critical Benchmark Animal Health Ltd
Publication of PT2686011T publication Critical patent/PT2686011T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/10011Birnaviridae
    • C12N2720/10021Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/10011Birnaviridae
    • C12N2720/10022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/10011Birnaviridae
    • C12N2720/10034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT127252872T 2011-03-16 2012-03-14 Vacina contra npi PT2686011T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO20110402 2011-03-16
NO20110650A NO332608B1 (no) 2011-03-16 2011-05-02 Levende avirulent IPNV og vaksine for profylakse eller behandling av IPN-sykdom hos fisk

Publications (1)

Publication Number Publication Date
PT2686011T true PT2686011T (pt) 2017-11-23

Family

ID=46207632

Family Applications (1)

Application Number Title Priority Date Filing Date
PT127252872T PT2686011T (pt) 2011-03-16 2012-03-14 Vacina contra npi

Country Status (12)

Country Link
US (2) US20140072591A1 (pt)
EP (1) EP2686011B8 (pt)
JP (1) JP2014513932A (pt)
AU (1) AU2012203610A1 (pt)
CA (1) CA2830184A1 (pt)
CL (1) CL2013002631A1 (pt)
DK (1) DK2686011T3 (pt)
ES (1) ES2647073T3 (pt)
NO (2) NO332608B1 (pt)
PT (1) PT2686011T (pt)
RU (1) RU2013146020A (pt)
WO (1) WO2012078051A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201400311D0 (en) * 2014-01-08 2014-02-26 Aqua Gen As Treating Susceptibility
CA2954876A1 (en) * 2014-07-11 2016-01-14 Fundacion Fraunhofer Chile Research Agent with antiviral properties for preventing or treating individuals exposed to a virus of the birnaviridae family
GB2533618B (en) * 2014-12-23 2019-11-13 The Marine Biological Ass Of The United Kingdom Type B DWV for use in superinfection exclusion protection of Apis mellifera against Type A DWV
GB201505310D0 (en) 2015-03-27 2015-05-13 Fvg Ltd IPN virus genome mutations and codon interactions
CA3011920A1 (en) * 2016-02-02 2017-08-10 Benchmark Animal Health Limited Methods of producing viruses
WO2023160425A1 (zh) * 2022-02-24 2023-08-31 中国水产科学研究院黑龙江水产研究所 一种鲑鳟鱼传染性造血器官坏死病和传染性胰脏坏死病单价佐剂疫苗及其二联佐剂疫苗和制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3353599A (en) * 1998-03-31 1999-10-18 University Of Maryland Biotechnology Institute A method for generating nonpathogenic, infectious pancreatic necrosis virus (ipnv) from synthetic rna transcripts

Also Published As

Publication number Publication date
WO2012078051A2 (en) 2012-06-14
DK2686011T3 (da) 2017-11-27
EP2686011B8 (en) 2017-10-04
JP2014513932A (ja) 2014-06-19
US20160122728A1 (en) 2016-05-05
NO20110650A1 (no) 2012-09-17
CA2830184A1 (en) 2012-06-14
WO2012078051A3 (en) 2012-12-27
NO332608B2 (no) 2012-11-19
ES2647073T3 (es) 2017-12-19
EP2686011B1 (en) 2017-08-30
NO2686011T3 (pt) 2018-01-27
NO332608B1 (no) 2012-11-19
NZ615974A (en) 2015-09-25
EP2686011A2 (en) 2014-01-22
AU2012203610A1 (en) 2013-10-17
CL2013002631A1 (es) 2014-07-25
RU2013146020A (ru) 2015-04-27
US20140072591A1 (en) 2014-03-13

Similar Documents

Publication Publication Date Title
GB201005005D0 (en) New vaccine
EP2683400A4 (en) ADJUVANZIA ON LISTERIA BASE
IL231043A (en) vaccine
EP2755680A4 (en) PARTICULATE VACCINE FORMULATIONS
GB201119999D0 (en) Vaccine
PT2686011T (pt) Vacina contra npi
EP2763699A4 (en) VACCINE
EP2771453A4 (en) DIATOM-BASED VACCINES
ZA201402071B (en) Vaccine therapy
ZA201306245B (en) Combination vaccines
GB201014965D0 (en) Vaccine
ZA201404512B (en) Malaria vaccine
GB201120000D0 (en) Vaccine
GB201013006D0 (en) Vaccine
GB201006324D0 (en) Vaccine
ZA201302154B (en) Vaccine
GB201121647D0 (en) Vaccine
GB201108256D0 (en) Vaccine
GB201108984D0 (en) Vaccines
GB201108986D0 (en) Vaccines
GB201108982D0 (en) Vaccines
GB201109294D0 (en) Novel vaccine
GB201106170D0 (en) Bacterial vaccine
GB201012283D0 (en) Vaccine
GB201007589D0 (en) Vaccine